Category Archives: "INforMS"

Multiple sclerosis clinical trials more successful than other diseases
Clinical trials for multiple sclerosis (MS) therapies demonstrate a success rate that is nearly triple that of other diseases, with small [...]
High dose vitamin D could treat multiple sclerosis, scientists find
Taking large doses of the recommended daily dose of vitamin D could be a cheap and simple treatment for multiple sclerosis, say [...]
Can we vaccinate against PML in multiple sclerosis?
“Both active vaccination/treatment with major capsid protein VP1 of JC polyoma virus and passive vaccination/treatment with broadly [...]
MedDay misses endpoint in phase III multiple sclerosis vision loss trial
A Phase III trial of MedDay's multiple sclerosis drug has missed its primary endpoint. The drug, which made headlines in April when it [...]
Brain cell death may cause multiple sclerosis
Scientists say they’ve pinpointed the brain cell deaths that seem to trigger MS, and their research could lead to a new treatment. It [...]
New drug is first to treat Progressive Multiple Sclerosis
Studies show that ocrelizumab works for both the relapsing and progressive forms of MS. Symptoms come and go in most cases of multiple [...]
Poor visual symptoms in multiple sclerosis patients
Multiple sclerosis (MS) patients with histories of neuro-ophthalmic symptoms performed poorly on neuropsychological tasks, according to a [...]
Multiple sclerosis and the prevalence of sleep disorders, epileptic seizures
Sleep disorders and epileptic seizures are of higher prevalence in those with multiple sclerosis. Multiple sclerosis is a chronic disease [...]
Multiple sclerosis causes psychiatric symptoms
As a chronic neurological condition, it should come as no surprise that multiple sclerosis can produce psychiatric problems. In fact, [...]
Cellular target opens new pathway for multiple sclerosis therapy
MedicalResearch.com Interview with: Dr. Vittorio Gallo PhD Center for Neuroscience Research Children’s Research [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last